Skip to content
Open access

Novel cholesterol-high-density lipoprotein-glucose index is associated with 1-year recurrence of atrial fibrillation after catheter ablation

Oct 2026 · Frontiers in Cardiovascular Medicine · Vol 13 · 0 citations · 32 references

TL;DR

The CHG index is an independent risk marker for 1-year recurrence after AF ablation and demonstrates superior discriminative ability compared to the TyG index.

Abstract

Insulin resistance (IR) plays a pivotal role in the pathogenesis of atrial fibrillation (AF). The novel cholesterol-high-density lipoprotein-glucose (CHG) index, which integrates total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and fasting blood glucose (FBG), has not been validated for predicting AF recurrence following radiofrequency catheter ablation (RFCA). This study aimed to evaluate the association between the CHG index and 1-year AF recurrence after RFCA, and to compare its performance with the triglyceride-glucose (TyG) index. A retrospective cohort of 813 AF patients who underwent first-time RFCA was enrolled. The primary outcome was any atrial tachyarrhythmia lasting ≥ 30 s after a 3-month blanking period. Cox regression, ROC curve, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to assess predictive performance. During 1-year follow-up, 142 patients (17.5%) had recurrent atrial tachyarrhythmia, with significantly higher CHG levels in the recurrence group ( P  < 0.001). Each unit increase in the CHG index was associated with a 4.23-fold higher risk of recurrence (HR = 4.231, 95% CI: 3.406–5.257, P  < 0.001). The restricted cubic spline curve shows a dose-response relationship between CHG and AF recurrence. The CHG index yielded an AUC of 0.765, superior to TyG (AUC = 0.673). Adding the CHG index to the traditional risk model significantly improved NRI (0.434, P  < 0.001) and IDI (0.200, P  < 0.001), with greater improvement than adding the TyG index. Subgroup analyses demonstrated consistent predictive effects across different populations. The CHG index is an independent risk marker for 1-year recurrence after AF ablation and demonstrates superior discriminative ability compared to the TyG index.

Read PDF

Similar papers

Open access Sep 2026

Association between the triglyceride-high-density lipoprotein-glucose-body index and atrial fibrillation: a retrospective case-control study

Background The triglyceride-glucose (TyG) index is a surrogate marker of insulin resistance and has been associated with atrial fibrillation (AF) risk, but it does not capture adiposity. The triglyceride-high-density lipoprotein-glucose-body (TyHGB) index, which integrates lipid profile, glucose metabolism, and body ma...

Yun-Ling Geng, Xue-Bo Li, Yang Yang et al. · 0 citations
Open access Nov 2026

Predictive value of cholesterol, high-density lipoprotein and glucose (CHG) index combined with C-reactive protein for stroke risk: a cohort study

Systemic inflammation and insulin resistance (IR) are closely linked in cerebrovascular disease. Triglyceride–Glucose (TyG) index and cholesterol–high-density lipoprotein–glucose (CHG) index are proposed markers of IR. Yet no existing biomarker integrates an inflammatory marker with CHG index for stroke risk pred...

Jing-Xian Bai, Guan-Qun Xu, Tai Li et al. · 0 citations
Open access Oct 2026

The platelet-to-high-density-lipoprotein-cholesterol ratio: a promising biomarker for predicting major adverse cardiovascular events in the Chinese community-based population

Findings indicate that higher PHR is associated with an increased long-term risk of MACE and AMI among Chinese community-dwelling adults, suggesting that PHR may serve as a potential biomarker associated with cardiovascular risk.

L. Dong, Long Zhang, Fang-Fang Fan et al. · 0 citations
Open access Oct 2026

Association of blood glucose-6-phosphate dehydrogenase activity with atrial fibrillation and post-ablation recurrence: a single-center retrospective study

Oxidative stress contributes to atrial fibrillation (AF), while glucose-6-phosphate dehydrogenase (G6PD) supports cellular redox homeostasis by maintaining NADPH availability. We investigated the associations of blood G6PD activity with prevalent AF and 1-year recurrence after catheter ablation and evaluated its...

Mao-Cheng Gu, Jie-Song Pan, W. Gao et al. · 0 citations
Open access Oct 2026

Insulin resistance surpasses remnant cholesterol: the triglyceride–glucose index as a stronger predictor of coronary artery disease

Remnant cholesterol (RC), a lipid index representing the cholesterol amount in triglyceride-rich lipoproteins (such as VLDL and chylomicron remnants), is associated with coronary artery disease (CAD). The triglyceride/glucose index (TyG) is a marker of cardiometabolic disease. However, the usefulness of RC and th...

F. Sousa, M. Mendonca, G. Abreu et al. · 0 citations
Open access Oct 2026

Uric acid-to-high-density lipoprotein cholesterol ratio and incident vascular calcification in patients with type 2 diabetes mellitus: a retrospective cohort study

Background The uric acid-to-high-density lipoprotein cholesterol ratio (UHR) is a composite marker that has been associated with all-cause and cardiovascular mortality in individuals with diabetes mellitus (DM). However, evidence on the association between UHR and vascular calcification (VC) remains limited and is deri...

Tao-Yuan He, Xin Wang, Guo-Sheng Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.